Cargando…

Co-Administration of Vitamin E and Atorvastatin Improves Insulin Sensitivity and Peroxisome Proliferator-Activated Receptor-γ Expression in Type 2 Diabetic Patients: A Randomized Double-Blind Clinical Trial

BACKGROUND: Negative effects of statins on glucose metabolism have been reported. The present study aimed to investigate the effects of co-administration of vitamin E and atorvastatin on glycemic control in hyperlipidemic patients with type 2 diabetes mellitus (T2DM). METHODS: A randomized double-bl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabaei, Banafsheh Sadat, Mousavi, Seyedeh Neda, Rahimian, Aliasghar, Rostamkhani, Hadi, Mellati, Ali Awsat, Jameshorani, Maryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shiraz University of Medical Sciences 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919307/ https://www.ncbi.nlm.nih.gov/pubmed/35291435 http://dx.doi.org/10.30476/ijms.2021.89102.1981

Ejemplares similares

Liver X Receptor as a Possible Drug Target for Blood-Brain Barrier Integrity
por: Eskandari, Mahsa, et al.
Publicado: (2022)

The Best Cut-Off Value for HbA1c as a Screening Tool in Iranian Women With Gestational Diabetes Mellitus
por: Mousavi, Seyedeh Neda, et al.
Publicado: (2017)

A Report of High Triglyceride Level in Cord Blood of Iranian Newborns
por: Kazemi, Seyed Ali Naghi, et al.
Publicado: (2013)

Association of the CYP1A1 rs4646903 polymorphism with susceptibility and severity of coronary artery disease
por: Eskandari, Mahsa, et al.
Publicado: (2021)

Comparative Proteomics Study of Streptozotocin-induced Diabetic Nephropathy in Rats Kidneys Transfected with Adenovirus-mediated Fibromodulin Gene
por: Maleki, Akram, et al.
Publicado: (2014)

Peroxisome Proliferator-Activated Receptor Alpha Mediates the Beneficial Effects of Atorvastatin in Experimental Colitis
por: Basso, Paulo José, et al.
Publicado: (2021)

Involvement of peroxisome proliferator activated receptor-γ in the anti-inflammatory effects of atorvastatin in oxygen-glucose deprivation/reperfusion-stimulated RAW264.7 murine macrophages
por: Li, Hong-Yan, et al.
Publicado: (2016)

Vitamin D Levels and Lipid Response to Atorvastatin
por: Pérez-Castrillón, José Luis, et al.
Publicado: (2010)

Early Effects of Atorvastatin on Vitamin D and Parathyroid Hormone Serum Levels Following Acute Myocardial Infarction
por: Zarei, Batool, et al.
Publicado: (2019)

Population pharmacokinetic of paracetamol and atorvastatin with co‐administration of semaglutide
por: Langeskov, Emilie K., et al.
Publicado: (2022)

Evaluation of the Effect of Atorvastatin Administration on the Outcomes of Patients with Traumatic Brain Injury: A Double-blinded Randomized Clinical Trial
por: Soltani, Farhad, et al.
Publicado: (2021)

Correlation of serum vitamin D, adipose tissue vitamin D receptor, and peroxisome proliferator-activated receptor γ in women with gestational diabetes mellitus
por: Wang, Hui-Yan, et al.
Publicado: (2019)

Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
por: Ferrari, Silvia Martina, et al.
Publicado: (2015)

Development of Atorvastatin Calcium Biloaded Capsules for Oral Administration of Hypercholesterolemia
por: Senthilvel, Chitra Karthikeyini, et al.
Publicado: (2022)

Atorvastatin modulates the expression of aging-related genes in the brain of aging induced by D-galactose in mice
por: Motevalian, Manijeh, et al.
Publicado: (2021)

Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation
por: Ohshima, Kousei, et al.
Publicado: (2012)

Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis
por: Liu, Huang-Jun, et al.
Publicado: (2016)

Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases
por: Zhang, Su, et al.
Publicado: (2015)

Effect of peroxisome proliferator-activated receptor γ on inflammatory markers
por: Khazaei, Majid
Publicado: (2015)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

Preventive Effect of Atorvastatin (80 mg) on Contrast-Induced Nephropathy After Angiography in High-Risk Patients: Double-Blind Randomized Clinical Trial
por: Khosravi, Arezoo, et al.
Publicado: (2016)

Efficacy of atorvastatin administration after surgery in patients with chronic subdural hematoma
por: Xu, Wuhuan, et al.
Publicado: (2023)

Retracted: Development of Atorvastatin Calcium Biloaded Capsules for Oral Administration of Hypercholesterolemia
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Atorvastatin protects against postoperative neurocognitive disorder via a peroxisome proliferator-activated receptor-gamma signaling pathway in mice
por: Yang, Yinan, et al.
Publicado: (2020)

Corrigendum to “Comparison of Purgative Manna Drop and Phototherapy with Phototherapy Treatment of Neonatal Jaundice: A Randomized Double-Blind Clinical Trial” [Osong Public Health Res Perspect 2019;10(3):152–7]
por: Monsef, Amirreza, et al.
Publicado: (2020)

Circulating peroxisome proliferator-activated receptor γ is elevated in systemic sclerosis
por: Żółkiewicz, Jakub, et al.
Publicado: (2019)

The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration in vitro and in vivo
por: Li, Zhenbao, et al.
Publicado: (2017)

Co-Administration of Vonoprazan, Not Tegoprazan, Affects the Pharmacokinetics of Atorvastatin in Healthy Male Subjects
por: Hwang, Sejung, et al.
Publicado: (2021)

Physically Targeted Intravenous Polyurethane Nanoparticles for Controlled Release of Atorvastatin Calcium
por: Eftekhari, Behnaz Sadat, et al.
Publicado: (2017)

Underexpression of peroxisome proliferator-activated receptor (PPAR)γ in PAX8/PPARγ-negative thyroid tumours
por: Marques, A R, et al.
Publicado: (2004)

Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
por: Sato, H, et al.
Publicado: (2000)

Peroxisome Proliferator-Activated Receptor-γ in Amyotrophic Lateral Sclerosis and Huntington's Disease
por: Kiaei, Mahmoud
Publicado: (2008)

The pathophysiological function of peroxisome proliferator-activated receptor-γ in lung-related diseases
por: Huang, Tom Hsun-Wei, et al.
Publicado: (2005)

Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania Infection
por: Chan, Marion M., et al.
Publicado: (2012)

Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) in vitro
por: Alexander, Stephen PH, et al.
Publicado: (2012)

Antifibrotic effect by activation of peroxisome proliferator-activated receptor–γ in corneal fibroblasts
por: Pan, Hongwei, et al.
Publicado: (2009)

Targeting the Peroxisome Proliferator-Activated Receptor-γ to Counter the Inflammatory Milieu in Obesity
por: Corzo, Cesar, et al.
Publicado: (2013)

PPAR-γ Impairment Alters Peroxisome Functionality in Primary Astrocyte Cell Cultures
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2014)

Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders
por: Ren, Ping, et al.
Publicado: (2015)

Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor γ
por: McCormick, David L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5jk254c9lpv6hbrtaht10km129